US HB1613 | 2023-2024 | 118th Congress

Status

Spectrum: Slight Partisan Bill (Republican 23-11)
Status: Introduced on March 17 2023 - 25% progression
Action: 2023-03-24 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Drug Price Transparency in Medicaid Act of 2023

Sponsors


History

DateChamberAction
2023-03-24HouseReferred to the Subcommittee on Health.
2023-03-17HouseReferred to the House Committee on Energy and Commerce.
2023-03-17HouseIntroduced in House

Same As/Similar To

SB1038 (Same As) 2023-03-29 - Read twice and referred to the Committee on Finance.
HB3561 (Related) 2023-05-24 - Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.

Subjects


US Congress State Sources


Bill Comments

feedback